Warning: For research use only. Not for human consumption.
Each purchase includes 10 vials with 10 mg, powder form.

Retatrutide is a novel synthetic peptide designed as a multi-receptor agonist targeting GLP-1, GIP, and glucagon receptors. This advanced peptide belongs to a class of incretin-based molecules with high sequence specificity and receptor-binding affinity, enabling it to influence multiple metabolic pathways simultaneously. Retatrutide exhibits potent activity in regulating glucose metabolism, enhancing energy expenditure, and modulating lipid balance. Through its unique receptor interactions, this peptide demonstrates broad therapeutic potential in metabolic research, including studies on obesity, diabetes, and related conditions.